This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/business/520907-stock-futures-sink-covid-vaccine/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| Stock futures sink after US calls for pause of Johnson & Johnson Covid vaccine rollout due to health issues | Stock futures sink after US calls for pause of Johnson & Johnson Covid vaccine rollout due to health issues |
| (about 1 month later) | |
| US stock futures slid on Tuesday morning after US federal health officials called for a pause in the rollout of Johnson & Johnson's coronavirus vaccine amid concerns over rare blood clots. | US stock futures slid on Tuesday morning after US federal health officials called for a pause in the rollout of Johnson & Johnson's coronavirus vaccine amid concerns over rare blood clots. |
| Contracts on the Dow Jones sold off 200 points following the news. The S&P 500 futures were down 0.3% at 4,127, while Nasdaq also pivoted lower by 0.3%. A day earlier, all the three major indexes ended slightly below record levels. | Contracts on the Dow Jones sold off 200 points following the news. The S&P 500 futures were down 0.3% at 4,127, while Nasdaq also pivoted lower by 0.3%. A day earlier, all the three major indexes ended slightly below record levels. |
| Shares of Dow component Johnson & Johnson also sank almost 3% in pre-market trading on Tuesday. | Shares of Dow component Johnson & Johnson also sank almost 3% in pre-market trading on Tuesday. |
| “We are recommending a pause in the use of this vaccine out of an abundance of caution,” the US Food and Drug Administration (FDA) said in a Twitter post, pointing toward six “extremely rare” cases of people suffering a “severe type of blood clot” after being vaccinated. Over 6.8 million Americans have received the Johnson & Johnson vaccine, with even more having gotten the job internationally. | “We are recommending a pause in the use of this vaccine out of an abundance of caution,” the US Food and Drug Administration (FDA) said in a Twitter post, pointing toward six “extremely rare” cases of people suffering a “severe type of blood clot” after being vaccinated. Over 6.8 million Americans have received the Johnson & Johnson vaccine, with even more having gotten the job internationally. |
| The health agencies said they are reviewing data over six reported US cases of a severe blood clot in individuals after receiving the vaccine, and have recommended the pause "out of an abundance of caution," the FDA added. | The health agencies said they are reviewing data over six reported US cases of a severe blood clot in individuals after receiving the vaccine, and have recommended the pause "out of an abundance of caution," the FDA added. |
| Johnson & Johnson said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data. | Johnson & Johnson said in a statement that “no clear causal relationship” has been identified between the blood clots and the vaccine, adding it is working closely with regulators to assess the data. |
| For more stories on economy & finance visit RT's business section | For more stories on economy & finance visit RT's business section |